Phone: 1.510.856.5600|info@anthera.com

Investor Relations

We are focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs.

NASDAQ: ANTH
0.43
0.00 (0.00%)
4:00 PM ET on Mar 29, 2017
Delayed at least 20 minutes.
Day High N/A
Day Low N/A
52-Week High 4.40
Volume 274,267
Print Friendly